Navigation Links
Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
Date:8/21/2007

CHICAGO, Aug. 21 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), today announced the commencement of its collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), the lead governmental institute supporting biodefense research, under which the NIAID will conduct studies to evaluate cethromycin, the Company's late-stage antibiotic, as a treatment for anthrax and other high-priority biodefense agents. This collaboration is part of the U.S. Government's effort to accelerate the research and development of medical countermeasures through the crucial phase of drug development between basic research and acquisition of final products under Project BioShield.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGO)

Project BioShield provides the Department of Health and Human Services with the authority and funding to procure promising countermeasures for addition to the Strategic National Stockpile, which is the Center for Disease Control and Prevention's store of medical supplies to protect the American public in the event of a public health emergency. Project BioShield provides the NIAID, part of the National Institutes of Health, with the authority to support development of countermeasures toward possible future procurement with Project BioShield funds.

"We are very excited about our partnership with the NIAID as it allows us to leverage the financial and scientific resources of the U.S. Government's premier research institute to develop cethromycin as a broad spectrum medical countermeasure," said Dr. Michael T. Flavin, Chief Executive Officer. "With the
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
5. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
6. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
9. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
10. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Pa. , Aug. 3, 2015 ... specialty biotechnology company focused on developing aerosolized KL4 ... live teleconference and webcast at 8:30 a.m. Eastern Time ... management will discuss the 2015 second quarter financial ... company will issue a press release announcing the ...
(Date:8/3/2015)... 3, 2015 Your doctor has recommended surgery ... for the best possible outcome. Your orthopaedic foot and ... and now there,s a three-part online series ... the American Orthopaedic Foot & Ankle Society (AOFAS) ... avoid complications and heal as quickly as possible. ...
(Date:8/3/2015)... SAN FRANCISCO , Aug. 3, 2015  Sage ... generation of portable laboratory-quality cannabis potency measurement systems, announced ... PAC Bay Area Cruise Fundraiser. A limited number of ... the festivities and help a great cause while enjoying ... a scenic cruise around the San Francisco Bay at ...
Breaking Medicine Technology:Discovery Labs to Hold Conference Call on Tuesday August 11, 2015 to Discuss Second Quarter 2015 Financial Results and Other Business Updates 2Patient Guide: How to Prepare for Surgery 2Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2
... 1, 2011 PTC Therapeutics, Inc. (PTC) today announced ... of ataluren, an investigational new drug, in adults with ... Respiratory Journal . The published three-month data showed that ... chloride channel activity, CF-related cough and positive trends in ...
... READING, England and BEDMINSTER, N.J., June 30, 2011 ... Inc., today announced that the U.S. Food and Drug ... the management of breakthrough pain in cancer patients 18 ... and who are tolerant to opioid therapy for their ...
Cached Medicine Technology:Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 2Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 3Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 4Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 5Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 6FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 2FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 3FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 4FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 5FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 6FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 7FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 8
(Date:8/4/2015)... ... August 04, 2015 , ... Armadale Capital ... announced the closing of a $118 million FHA-insured loan modification refinancing for Johnston ... Smithfield and Clayton, North Carolina. JHSC is a joint venture of Johnston ...
(Date:8/4/2015)... ... August 04, 2015 , ... Oriental Trading Company, ... toys, novelties, and school supplies, has developed engaging and affordable teacher supplies based ... includes student rewards, classroom decorations, crafts and educational resources featuring Carle’s vibrant ...
(Date:8/4/2015)... ... 2015 , ... It is National Psoriasis Awareness Month, and we are reminded ... as dry, itching, burning or soreness of skin that may crack or bleed. , ... what’s right for them. Then, what is effective may stop working, so they have ...
(Date:8/4/2015)... ... ... The goal of looking younger – with a fresher, more rested appearance ... ideal is not. But minimally invasive procedures such as dermal fillers, tighteners or laser ... time, according to Valerie Goldburt, MD, PhD , of Advanced Dermatology P.C. ...
(Date:8/4/2015)... ... August 04, 2015 , ... Nathan’s Famous was recently featured ... medium, and large businesses making an impact in their industry. Andrew Tropeano, the host ... the famous hot dog maker now offers a 50% Reduced Fat All-Beef Frank ...
Breaking Medicine News(10 mins):Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 2Health News:Armadale Capital Inc. Refinances $118 Million for Johnston Health Services Corporation 3Health News:Oriental Trading Company Brings The World of Eric Carle Characters to Educators Through Classroom Supplies 2Health News:Oriental Trading Company Brings The World of Eric Carle Characters to Educators Through Classroom Supplies 3Health News:USA Medical Card Offers a Solution During National Psoriasis Awareness Month 2Health News:USA Medical Card Offers a Solution During National Psoriasis Awareness Month 3Health News:Considering fillers, tighteners or laser resurfacing? 2Health News:Considering fillers, tighteners or laser resurfacing? 3Health News:Considering fillers, tighteners or laser resurfacing? 4Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 2Health News:Celebrate Summer with Nathan’s Famous Original Selfie Sweepstakes 3
... with prostate cancer can improve their outcomes if they walk ... diagnosis, according to a recent study in Cancer Research ... "It appears that men who walk briskly after ... disease," said lead researcher Erin Richman, Sc.D., a research associate ...
... NEW YORK (May 23, 2011) -- Patients with ... clinical research study comparing two medications -- quetiapine ... and lithium, the gold-standard mood stabilizer. NewYork-Presbyterian ... sites nationally -- and the only site in ...
... 24, 2011For every year a person is homeless, the odds of ... to a report by St. Michael,s Hospital and Street Health. ... the lack of a health card, often because it has been ... in the journal Open Medicine , www.openmedicine.ca/article/view/368/407 , is ...
... May 24, 2011 The latest episode in ... " Global Challenges/Chemistry Solutions ," focuses on new ... are infected with an antibiotic-resistant bacterium that,s become ... This "superbug" is called methicillin-resistant Staphylococcus aureus, or ...
... , TUESDAY, May 24 (HealthDay News) -- Exercising ... why residents of Minneapolis-St. Paul find their city is now ... Every year, the American College of Sports Medicine (ACSM) ranks ... States, using the American Fitness Index (AFI). Although kicking the ...
... that their incomes start to rise not decline ... place says a Queen,s University School of Medicine professor. ... toward a Canadian-style system is feeble," says Jacalyn Duffin, ... medicine. "Physicians, incomes grew more quickly than those of ...
Cached Medicine News:Health News:Brisk walking could improve prostate cancer outcomes 2Health News:New study aims to improve long-term treatment for patients with bipolar disorder 2Health News:No health card means no family doctor for many homeless people 2Health News:New American Chemical Society podcast: Fast test to diagnose MRSA infections 2Health News:Twin Cities Take Top Ranking for Healthy Living 2